Production (Stage)
Phio Pharmaceuticals Corp.
PHIO
$2.96
$0.5020.33%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -6.69% | 17.44% | 14.30% | -13.67% | 31.83% |
| Total Depreciation and Amortization | -- | -100.00% | -97.06% | -20.93% | -8.51% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -25.00% | 246.67% | -57.14% | -74.07% | 51.69% |
| Change in Net Operating Assets | 144.91% | -1,007.55% | -28.38% | 111.33% | -155.08% |
| Cash from Operations | 29.80% | -9.90% | 11.64% | 15.15% | 18.28% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -48.75% | -- | -- | -- | -- |
| Repurchase of Common Stock | 0.00% | -- | 100.00% | -300.00% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -48.77% | -- | 100.00% | -100.17% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -101.16% | 138.94% | 11.81% | -6,206.06% | 101.14% |